Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 6781 AL 6795

A brief history of Aβ imaging

Cohen AD, Villemagne VL.

Alzheimers Dement. 2025 May;21(5):e70291. doi: 10.1002/alz.70291.

Current Developments in Alzheimer's Disease

Goetzl EJ.

Am J Med. 2025 Jan;138(1):15-20. doi: 10.1016/j.amjmed.2024.08.019. Epub 2024 Aug 27.

Biomarkers of synaptic degeneration in Alzheimer's disease

Cheng Q, Fan Y, Zhang P, Liu H, Han J, Yu Q, Wang X, Wu S, Lu Z.

Ageing Res Rev. 2025 Feb;104:102642. doi: 10.1016/j.arr.2024.102642. Epub 2024 Dec 17.

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease

Gonzalez-Ortiz F, Kirsebom BE, Yakoub Y, Gundersen JK, Pålhaugen L, Waterloo K, Selnes P, Jarholm JA, Gísladóttir B, Rongve A, Skogseth RE, Bråthen G, Aarsland D, Turton M, Harrison P, Zetterberg H, Villeneuve S, Fladby T, Blennow K.

Neurology. 2025 Jun 10;104(11):e213676. doi: 10.1212/WNL.0000000000213676. Epub 2025 May 15.

Non-coding RNA biomarkers in Alzheimer's disease

Mohammadpour M, Saeidi K, Ferdosi F, Khanifar H, Dadgostar E, Zakizadeh F, Abdolghaderi S, Khatami SH.

Clin Chim Acta. 2025 Aug 15;576:120427. doi: 10.1016/j.cca.2025.120427. Epub 2025 Jun 14.

Spotlight on Alzheimer's disease and related dementias research in East Asia

Le W, Shen L, Guo T, Xie F.

Alzheimers Dement. 2025 Jul;21(7):e70479. doi: 10.1002/alz.70479.

Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium

Verberk IMW, Gouda M, Antwi-Berko D, van Leeuwenstijn M, Bongers B, Houtkamp IM, van der Flier WM, Janelidze S, Hansson O, Bastard NL, Vandijck M, Hunter J, Honigberg L, Kirmess KM, Verghese PB, Blennow K, Zetterberg H, Meyers EA, Edelmayer RM, Teunissen C.

Alzheimers Dement. 2025 Oct;21(10):e70752. doi: 10.1002/alz.70752.

C-reactive protein-mediated dementia

Tang JM, Lu Q, Lin HX, Li JQ, Zhu XC, Ma T.

Psychogeriatrics. 2025 May;25(3):e70032. doi: 10.1111/psyg.70032.

Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta-analysis

Pahlke S, Kahale LA, Mahinrad S, Sousa-Pinto B, Vieira RJ, McAteer MB, Claessen T, Contador J, Hofmann A, Kuchenbecker LA, Machado LS, Warmenhoven N, Yakoub Y, Palmqvist S, Schindler SE, Teunissen C, Whitson HE, Zetterberg H, Edelmayer R, Tampi MP.

Alzheimers Dement. 2025 Nov;21(11):e70828. doi: 10.1002/alz.70828.

Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial

Lu M, Kim MJ, Collins EC, Shcherbinin S, Ellinwood AK, Yokoi Y, Brooks DA, Hansson O, Knopman DS, Sims JR, Mintun MA.

JAMA Neurol. 2025 Dec 1;82(12):1251-1256. doi: 10.1001/jamaneurol.2025.3869.

Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease

Salvadó G, Janelidze S, Bali D, Dolado AO, Therriault J, Brum WS, Pichet Binette A, Stomrud E, Mattsson-Carlgren N, Palmqvist S, Coomans EM, Teunissen CE, van der Flier WM, Rahmouni N, Benzinger TLS, Gispert JD, Blennow K, Doré V, Feizpour A, Rowe CC, Alcolea D, Fortea J, Villeneuve S, Johnson SC, Rosa-Neto P, Petersen RC, Jack CR Jr, Schindler SE, Suárez-Calvet M, Ossenkoppele R, Hansson O; ADNI, ALFA, and PREVENT-AD Study Groups.

JAMA Neurol. 2025 Nov 1;82(11):1122-1134. doi: 10.1001/jamaneurol.2025.3217.

Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity

Mielke MM, Evans JK, Neiberg RH, Molina-Henry DP, Marcovina SM, Johnson KC, Carmichael OT, Rapp SR, Sachs BC, Ding J, Shappell HM, Luchsinger JA, Espeland MA, Hayden KM.

JAMA Netw Open. 2025 Feb 3;8(2):e2458149. doi: 10.1001/jamanetworkopen.2024.58149.

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers

Bouteloup V, Villain N, Vidal JS, Gonzalez-Ortiz F, Yuksekel I, Santos C, Schraen-Maschken S, Pellegrin I, Lehmann S, Blennow K, Chêne G, Hanon O, Dufouil C, Planche V; MEMENTO and the BALTAZAR Study Groups.

JAMA Neurol. 2025 May 1;82(5):506-515. doi: 10.1001/jamaneurol.2025.0142.

Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease

Leuzy A, Bollack A, Pellegrino D, Teunissen CE, La Joie R, Rabinovici GD, Franzmeier N, Johnson K, Barkhof F, Shaw LM, Arkhipenko A, Schindler SE, Honig LS, Moscoso Rial A, Schöll M, Zetterberg H, Blennow K, Hansson O, Farrar G.

Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528.

Plasma p-tau immunoassays in clinical research for Alzheimer's disease

Teunissen CE, Kolster R, Triana-Baltzer G, Janelidze S, Zetterberg H, Kolb HC.

Alzheimers Dement. 2025 Jan;21(1):e14397. doi: 10.1002/alz.14397. Epub 2024 Dec 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias